IDEX Corporation

What they do

IDEX designs, produces, and distributes mission-critical components and systems for specialty applications, including precision fluidics, pumps, sealing solutions, fire and safety products, and dispensing equipment. The company operates through over 50 wholly-owned subsidiaries, serving end markets like life sciences, data centers, semiconductor, water, energy, and agriculture. IDEX employs the '8020' operating framework to focus on high-value products and customers.

Revenue drivers

• Health & Science Technologies (HST) — Largest segment, 43% of 2025 net sales. Sells precision fluidics, optics, pumps, sealing solutions, and material processing technologies to life sciences, pharmaceutical, medical/dental, data center, and semiconductor markets.
• Fluid & Metering Technologies (FMT) — 35% of 2025 net sales. Provides pumps, valves, and water/energy/agriculture metering solutions for industrial and municipal applications.
• Fire & Safety/Diversified Products (FSDP) — 22% of 2025 net sales. Includes fire & safety equipment, dispensing systems, and BAND-IT industrial clamps, with end markets affected by capital spending and international demand.

Recent performance

In Q2 2026 (three months ended June 30, 2026), IDEX reported record net sales of $920.6 million, up 6% reported and 5% organically year-over-year. Diluted EPS was $1.93 (up 11%), record adjusted diluted EPS was $2.32 (up 12%), and record orders exceeded $1 billion, up 29% reported and 28% organically. Gross margin expanded 100 bps to 46.3%, and operating cash flow was $200.0 million (140% of net income). For full-year 2025, net sales were $3.46 billion with diluted EPS of $6.41.

Strategy

Management is focused on strengthening positions in targeted advantaged markets (data center, semiconductor, space/defense, food & beverage, pharmaceutical) by integrating capabilities and advancing the 8020 operating framework. The strategy supports sustained organic growth while enabling disciplined bolt-on acquisitions. Capital deployment is balanced, returning capital via dividends and share repurchases ($248 million repurchases and $213 million dividends in 2025). IDEX also continues productivity improvements and platform optimization savings from restructuring.

Risks

• Market cyclicality — Demand in core industrial markets (chemical, energy, agriculture, automotive) remains soft, which could pressure FMT and FSDP segments.
• Acquisition integration — IDEX's growth strategy relies on acquisitions, which carry integration risks, potential undisclosed liabilities, and may not perform as expected.
• Tariff and trade policy exposure — IDEX is subject to tariffs, as evidenced by a $14.7 million revenue reduction in Q2 2026 for customer rebates under IEEPA tariff refunds.
• Foreign exchange and global conditions — International sales (49% of 2025 revenue) expose IDEX to currency fluctuations, geopolitical conflicts, and economic conditions outside the U.S.

Outlook

Management raised full-year 2026 guidance: organic sales growth of 5-6% (up from 3-4%) and adjusted diluted EPS of $8.70-$8.85 (up ~10% year-over-year at midpoint). Q3 2026 organic sales are expected to grow 5-7%, with adjusted EPS of $2.20-$2.25. Management sees continued HST strength in data centers, semiconductors, space/defense, and pharma, while FMT water markets remain positive but core industrial stays flat; FSDP faces near-term headwinds.